Report: J&amp;J in Talks to Acquire Guidant
437703
Health care giant Johnson &amp; Johnson is reportedly in advanced negotiations to acquire medical device maker Guidant Corp. for more than $24 billion.
478171
INDIANAPOLIS - Health care products giant Johnson &amp; Johnson&#39;s $25.4 billion acquisition of Guidant Corp., formally announced Thursday, could face a tough review from regulators because of their competition in the coronary stent market, analysts say.
497700
NEW YORK -- Johnson &amp; Johnson, the New Jersey-based drug and health care products company, is reportedly in advanced negotiations to buy Guidant Corp.
605466
Johnson &amp; Johnson last night struck a deal to acquire Guidant, the US cardiac treatment group for $25.4bn, in a move that will give it access to one of the fastest growing areas in health care.
570795
Health care and consumer products maker Johnson & Johnson  on Sunday was close to finalizing details of a &#36;24 billion cash and stock acquisition of medical-device maker Guidant Corp. , according to people familiar with the matter.
560518
New York (dpa) - Health-care conglomerate Johnson &amp; Johnson is in advanced negotiations to buy defibrillator maker Guidant Corp.
505067
Johnson &amp; Johnson said on Wednesday that it will acquire device manufacturer Guidant Corp. for $25.4 billion. Under the terms of the deal announced on Wednesday, each Guidant share will be exchanged for $30.40
200948
Johnson &amp; Johnson said Wednesday night that it would acquire Indianapolis-based medical device manufacturer Guidant Corp. for $25.4 billion.
341615
Johnson &amp; Johnson&#39;s$25.4bn purchase of Guidant, a medical device maker, will give the big US medical group a range of fast-growing products that manage patients&#39; heart rhythms, a move that will shake up the US medical device industry.
6925
Johnson &amp; Johnson (JNJ.N: Quote, Profile, Research) on Thursday said it does not see any significant antitrust roadblocks getting in the way of its $25.4 billion acquisition of medical device maker Guidant Corp.
572995
Exelon Corp. (EXE.N: Quote, Profile, Research) is in talks to buy New Jersey utility Public Service Enterprise Group Inc.&#39;s (PEG.
21679
The anticipated merger of Guidant Corp.  and Johnson & Johnson could give an unintended boost to Boston  Scientific Corp. if Guidant's drug-coated stent launch is  delayed, said analysts looking at the implications of a  potential deal.
506558
Johnson &amp; Johnson is in advanced talks to buy cardiovascular device maker Guidant Corp. for more than $24 billion, a newspaper report said Tuesday.
731068
Johnson & Johnson will acquire the cardiac device manufacturer for $25.4 billion. The acquisition is the largest business deal in J&J's 118-year history
180365
Blog: Company is also in talks with the group that has sued it, according to a report in The Wall Street Journal.
312826
Johnson &amp; Johnson announced that it will acquire Guidant Corp., one of the world&#39;s top makers of cardiac devices, for $25.4 billion US.
607732
Shares of cardiovascular device maker  Guidant Corp. GDT.N jumped 6 percent on Tuesday, following a  report that Johnson & Johnson JNJ.N is in advanced talks to  buy it for more than $24 billion.